AkouosÂ Inc (AKUS) Peer Comparison

$13.29

$0.00 (0.00%)

As on 09-Dec-2022 09:30EDT

Market cap

$491 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Edit

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Market cap ($ Mln)	491	27
Revenue ($ Mln)	--	0
Net Profit ($ Mln)	-92.59	-70.23
Net Margin (%)	-14,862.28	-21,610.46
RoE (%)	-47.50	-217.20
Price to Earnings	--	--
Price-To-Book	2.72	1.51

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Operating Revenue	0.00	0.33
Cost of Revenue	0.00	0.00
Gross Profit	--	--
Operating Expenses	93.22	67.42
Operating Profit (EBIT)	-93.22	-67.09
Other Income	0.62	0.00
Profit before Tax	-92.59	-70.00
Provision for Tax	0.00	-68.85
Profit after Tax (Net Income)	-92.59	-70.23
Minority Interest	0.00	0.00
Consolidated Profit	-92.59	-70.23

Liabilities ($ Mln)

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Shareholder's Funds	180.84	17.65
Minority Interest	0.00	0.00
Non-Current Liabilities	34.58	13.08
Current Liabilities	10.09	26.60
Total Liabilities	278.76	126.97

Assets ($ Mln)

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Non-Current Assets	51.02	20.09
Current Assets	174.49	37.24
Total Assets	278.76	126.97
Total Debt*	35.37	0.00
Net Current Assets	164.41	10.64

Cashflow ($ Mln)

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Cash From Operating Activities	-63.73	-51.17
Cash Flow from Investing Activities	117.62	38.15
Cash from Financing Activities	0.22	79.62
Net Cash Inflow / Outflow	54.11	--

Ratios

Profitability Ratios

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
ROCE (%)	-29.56	-60.21
ROE (%)	-47.50	-217.20
ROA (%)	-33.91	-65.01
EBIT Margin (%)	--	-21,080.92
Net Margin (%)	-14,862.28	-21,610.46
Cash Profit Margin (%)	--	-0.01

Growth Ratios

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Revenue Growth (%)	--	-35.00
EBIT Growth (%)	-23.30	-14.47
Net Profit Growth (%)	-24.65	-17.91
EPS Growth (%)	-4.24	17.03
Book Value Growth (%)	-35.14	-83.21

Valuation Ratios

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Price / Earnings	-3.33	-2.23
Price / Book Value	1.24	1.50
Dividend Yield (%)	--	--
EV/EBITDA	-1.03	-0.82
Market Cap ($ Cr)	--	--

Solvency Ratios

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Debt to Equity	0.00	0.39
Short term debt to equity ratio	0.00	0.00
Current Ratio	17.30	1.40
Quick Ratio	17.30	1.40
Interest Coverage	-117.86	-25.29

Operating Efficiency Ratios

	AkouosÂ Inc (AKUS)	Applied Genetic (AGTC)
Debtors to sales (%)	--	0.00
Asset Turnover	0.00	0.00
Receivable days	--	0.00
Inventory Days	--	--
Payable days	--	--
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly